This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Sandoz Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of David Gregory Ahern
Introduction
David Gregory Ahern is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of inhalation devices, particularly through his innovative designs that enhance the delivery of medicaments. His work is characterized by a focus on improving user experience and efficacy in medication administration.
Latest Patents
David Gregory Ahern holds 1 patent for an inhaler device. This patent describes inhaler devices equipped with medicament carriers that contain individual pockets or blisters of powdered medicament, which are covered by a lidding sheet, such as a lidding foil. The design includes a common actuator that controls the movement of an indexing system for advancing a dose and an opening system for releasing a dose. Notably, the progression of the opening system is disproportional to the progression of the indexing system during the movement of the common actuator, which enhances the functionality of the device.
Career Highlights
Ahern's career is marked by his role at Sandoz AG, where he has been instrumental in developing innovative inhalation technologies. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of respiratory medications.
Collaborations
David Gregory Ahern has collaborated with notable colleagues, including Robin Craig Cocker and James Anthony Tibbatts. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David Gregory Ahern's contributions to inhaler technology exemplify the importance of innovation in the medical field. His patent for an inhaler device showcases his commitment to improving patient care through effective medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
